Detalhe da pesquisa
1.
Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh.
Microb Genom
; 9(9)2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750750
2.
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century.
J Clin Tuberc Other Mycobact Dis
; 27: 100299, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35146133
3.
Multidrug-resistant patients receiving treatment in Niger who are infected with M. tuberculosis Cameroon family convert faster in smear and culture than those with M. tuberculosis Ghana family.
Tuberculosis (Edinb)
; 122: 101922, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32275231
4.
Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen.
Int J Infect Dis
; 100: 357-365, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829049
5.
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements.
Respir Med
; 161: 105844, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32056722
6.
Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.
PeerJ
; 7: e7564, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31523514
7.
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.
Sci Rep
; 8(1): 3246, 2018 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29459669
8.
The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology.
EBioMedicine
; 37: 410-416, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341041